Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a topical cosmetic cream formulation containing autologous platelet-rich fibrin (PRF) developed by the Poznan University of Medical Sciences for the treatment of skin ageing. PRF is a second-generation platelet concentrate obtained from the patient's own blood, containing a high concentration of platelets, leukocytes, and growth factors such as Platelet-Derived Growth Factor (PDGF), Transforming Growth Factor-beta (TGF-β), and Vascular Endothelial Growth Factor (VEGF) within a three-dimensional fibrin matrix. The cream is designed to promote skin rejuvenation by stimulating collagen production, enhancing angiogenesis, and facilitating tissue repair mechanisms. Clinical evaluation in a phase 2 trial (NCT07359924) has demonstrated improvements in skin hydration, elasticity, and barrier function, as evidenced by a significant decrease in transepidermal water loss (TEWL).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on platelet-rich fibrin cream.